September 2026
All columns and Brief analyses.
10 results
US second-quarter growth revised up to a 2.2 per cent annualised rate
The US Bureau of Economic Analysis raised its estimate of annualised real growth in the second quarter from 1.5 per cent to 2.2 per cent. Revised investment, consumer and government spending accounted for much of the change. Growth in real final sales to private domestic purchasers was also raised to 4.6 per cent. These are annualised quarter-on-quarter rates, not comparisons with the same quarter last year.
US Supreme Court temporarily clears third-country deportations
The US Supreme Court allowed the Trump administration to continue deporting migrants to countries other than their own while litigation proceeds. It paused a lower-court order requiring an opportunity to object to safety risks before removal. Three justices opposed the temporary relief. The court will hear the case in December; the policy’s ultimate legality and migrants’ chance to challenge danger at the destination remain before the court.
Webb charts a possible first-star chemical clue beside 17 metal-poor galaxies
Webb observations identified a group of 17 galaxies with unusually little heavy-element content near a gas cloud whose chemical ratios may reflect the universe’s first stars. The result gives astronomers a place to test that interpretation through further observations. It does not show the first stars directly, and other histories of how the gas gained its elements remain possible.
Wilkes Basin review finds a major blind spot in Antarctic ice forecasts
A new review of East Antarctica’s Wilkes Subglacial Basin finds that a region holding enough ice to raise global sea level by three to four metres remains poorly measured. Researchers report evidence of past retreat and changes along coastal ice, while the temperature threshold and future pace remain uncertain. They call for a coordinated international programme to map the seafloor, ice edge and inland basin.
WRN inhibitor records seven partial responses in an early cancer trial
Initial clinical results are out for the experimental WRN inhibitor RO7589831 in patients with advanced cancers carrying particular DNA repair defects. Seven of 66 evaluable patients had confirmed partial tumor responses in a phase 1 trial. The study primarily investigated safety and suitable dosing. The responses support further testing in this patient group, but they do not establish an approved treatment or a definitive clinical benefit.
A small fin sample, a larger question for fish stocks
A haddock age clock can spare individual fish, but its value to a stock ledger depends on accuracy outside the test sample.
Advance payments behind NETSOL’s cash-flow leap
NETSOL grew revenue and margins. Its jump in operating cash needs a closer look at advance customer payments and one renewed licence contract.
EU defence projects move from selection to the funding test
The EU selected five joint defence projects, with Ukraine in four. The decision puts countries in one framework; funding and procurement depend on further decisions.
For a small business, Muse starts with the connections
Meta is opening business accounts to Muse. Time saved has to include connecting tools, correcting drafts and approving actions.
Gimlet’s speed target depends on a data-center launch
A private deployment already serves tokens on Cerebras hardware. Gimlet’s broader service and target of 3,000 tokens per second depend on a new data center and measurements with a clear workload boundary.